Aug 13, 2020
VistaGen Therapeutics Reports Fiscal 2021 First Quarter Financial Results and Highlights CNS Pipeline and Business Progress
Aug 11, 2020
American Society of Ketamine Physicians, Psychotherapists and Practitioners Announces Standards of Practice in the Therapeutic Use of Subanesthetic Ketamine
May 27, 2020
The Ketamine Healing Clinic of Los Angeles, California, is Offering New "Fountain of Youth Infusion" with the Combination of NAD and Ketamine
May 27, 2020
VistaGen and Nuformix Announce Agreement to Develop Novel Patentable Cocrystalline Forms of AV-101 for Treatment of Multiple CNS Conditions
May 27, 2020
Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder
May 21, 2020
Insomnia Data 2020: US Leads in Global Insomnia Clinical Trials, Germany Leads Major European Markets and Japan Has Top Spot in Asia
May 14, 2020
Luye Pharma Grants Exclusive Promotion Rights to Moksha8, Deepening Strategic Presence in Latin America for CNS Business
Apr 16, 2020
Innovative Approaches to Healthcare Lead to the Psychedelic Biotech Market's Inception
Mar 26, 2020
2020 Sertraline Markets: Trends & Developments, Major Players, Patents, and More
Mar 23, 2020
Ketamine Therapy Essential Service During COVID-19 Pandemic
Mar 17, 2020
Major Depressive Disorder (MDD) Industry Assessment, 2017-2028 - Patient Population, Therapeutic Approaches, Pipeline Analysis, Market Size & Trends, Opportunities, Impact of Upcoming Therapies
Feb 27, 2020
Segal Trials Screens its First Patient in a study of Psilocybin for Major Depressive Disorder
Feb 20, 2020
Researchers Say Extended Antidepressant Use Creates Physical Dependence
Feb 13, 2020
VistaGen Therapeutics Reports Fiscal 2020 Third Quarter Financial Results and Provides CNS Pipeline Overview
Feb 10, 2020
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries
Jan 08, 2020
Are some antidepressants less risky for pregnant women?
Jan 06, 2020
Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%
Jan 01, 2020
Global & Chinese Lobeline hydrochloride Market Insights 2019: Analysis and Forecast 2019-2024 - ResearchAndMarkets.com
Dec 26, 2019
Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Dec 18, 2019
The Ketamine Fund Donates 400 Free Treatments To Veterans